Avalo Therapeutics (AVTX) Current Assets (2014 - 2026)
Avalo Therapeutics (AVTX) posted Current Assets of $88.8 million for Q1 2026, down 15.63% on a QoQ basis from $105.3 million in Q4 2025, and down 30.03% year-over-year from $126.9 million in Q1 2025.
Avalo Therapeutics (AVTX) Current Assets (2014 - 2026) Analysis & Trends
Avalo Therapeutics' Current Assets history runs 13 years deep, the most recent figure standing at $88.8 million for Q1 2026.
- Quarterly Current Assets fell 30.03% year-over-year to $88.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $88.8 million (down 30.03% YoY) and the FY2025 annual result came in at $105.3 million, down 24.19% from the prior year.
- Current Assets was $88.8 million for Q1 2026 at Avalo Therapeutics, down from $105.3 million in the prior quarter.
- Across five years, Current Assets topped out at $138.9 million in Q4 2024 and bottomed at $7.5 million in Q2 2023.
- A 5-year average of $66.2 million and a median of $86.1 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets tumbled 74.74% — and 2024, when it jumped 1554.44%.
- Avalo Therapeutics' Current Assets stood at $16.4 million in 2022, then tumbled by 48.86% to $8.4 million in 2023, then soared by 1554.44% to $138.9 million in 2024, then decreased by 24.19% to $105.3 million in 2025, then retreated by 15.63% to $88.8 million in 2026.
- Business Quant data shows AVTX's Current Assets at $88.8 million in Q1 2026, $105.3 million in Q4 2025, and $113.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - | 88.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88.83 Mn |
| Dec 31, 2025 | 105.29 Mn |
| Sep 30, 2025 | 113.85 Mn |
| Jun 30, 2025 | 115.19 Mn |
| Mar 31, 2025 | 126.94 Mn |
| Dec 31, 2024 | 138.89 Mn |
| Sep 30, 2024 | 86.15 Mn |
| Jun 30, 2024 | 95.89 Mn |
| Mar 31, 2024 | 111.21 Mn |
| Dec 31, 2023 | 8.40 Mn |
| Sep 30, 2023 | 12.66 Mn |
| Jun 30, 2023 | 7.52 Mn |
| Mar 31, 2023 | 19.25 Mn |
| Dec 31, 2022 | 16.42 Mn |
| Sep 30, 2022 | 19.45 Mn |
| Jun 30, 2022 | 15.02 Mn |
| Mar 31, 2022 | 43.66 Mn |
| Dec 31, 2021 | 61.85 Mn |
| Sep 30, 2021 | 77.01 Mn |
| Jun 30, 2021 | 47.36 Mn |